CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02576665
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:25.184580+00:00
Published At: 2020-02-07T00:00:00+00:00
Record Updated At: 2020-02-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Colorectal Cancer", "Triple Negative Breast Cancer", "Pancreatic Cancer", "Non-Small Cell Lung Cancer", "Head and Neck Cancer", "Ovarian Cancer", "Lymphoma", "Sarcoma", "Bladder Cancer", "Melanoma", "IDH1 Mutated Solid Tumors", "IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-07"
protocolSection.identificationModule.nctId: "NCT02576665"
protocolSection.identificationModule.officialTitle: "A Phase 1b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.